BioPower Operations Corporation Research and Development Expense
BioPower Operations Corporation reported Research and Development Expense of $248.77 thousand for the 3-month period ending 2023-05-31, per its 10-Q filed 2023-08-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2023-08-22
- BioPower Operations Corporation research and development expense for the quarter ending 2023-05-31 was $248.77K.
- BioPower Operations Corporation research and development expense for the quarter ending 2023-02-28 was $432.37K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month |
|---|---|---|
| 2023-05-31 | $248.77K 10-Q · filed 2023-08-22 | $681.14K 10-Q · filed 2023-08-22 |
| 2023-02-28 | $432.37K 10-Q/A · filed 2023-08-22 |